Haemonetics (STU:HAZ) Total Liabilities: €1,384 Mil (As of Mar. 2026)


STU:HAZ Haemonetics Corp STU:HAZ
83 GF Score
Price €64.50
GF Value €74.31
! 4 Warning Signs
View Full Analysis

What is Haemonetics Total Liabilities?

Haemonetics STU:HAZ -1.53% 83 Total Liabilities is €1,384 Mil as of Mar. 2026. GuruFocus rates STU:HAZ with a GF Score™ of 83/100 and a GF Value™ of €74.31. The stock has 4 warning signs investors should review.

Haemonetics's Total Liabilities for the quarter that ended in Mar. 2026 was €1,384 Mil.

Haemonetics's quarterly Total Liabilities declined from Sep. 2025 (€1,357.22 Mil) to Dec. 2025 (€1,348.84 Mil) but then increased from Dec. 2025 (€1,348.84 Mil) to Mar. 2026 (€1,383.66 Mil).

Haemonetics's annual Total Liabilities increased from Mar. 2024 (€1,136.78 Mil) to Mar. 2025 (€1,507.85 Mil) but then declined from Mar. 2025 (€1,507.85 Mil) to Mar. 2026 (€1,383.66 Mil).

Haemonetics Total Liabilities Historical Data

* Premium members only.

The historical data trend for Haemonetics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Haemonetics Total Liabilities Chart

Haemonetics Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,008.16 1,043.12 1,136.78 1,507.85 1,383.66

Haemonetics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,507.85 1,369.68 1,357.22 1,348.84 1,383.66
STU:HAZ
83GF Score
Haemonetics Corp STU:HAZ
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Haemonetics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Haemonetics's Total Liabilities for the fiscal year that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=244.448+(1054.924+51.374
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+32.912+0+0)
=1,384

Total Liabilities=Total Assets (A: Mar. 2026 )-Total Equity (A: Mar. 2026 )
=2072.475-688.817
=1,384

Haemonetics's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=244.448+(1054.924+51.374
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+32.912+0+0)
=1,384

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=2072.475-688.817
=1,384

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €1,384 Mil mean?
Haemonetics (STU:HAZ) has a Total Liabilities of €1,384 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Haemonetics and its competitors.
Is Haemonetics' Total Liabilities too high?
Haemonetics' current Total Liabilities is €1,384 Mil. Overall, Haemonetics has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does Haemonetics' Total Liabilities compare to ITGR and IRTC?
Haemonetics' Total Liabilities of €1,384 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Haemonetics and its competitors. Haemonetics's current Total Liabilities is €1,384 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haemonetics stock overvalued right now?
Haemonetics (STU:HAZ) has a current Total Liabilities of €1,384 Mil. The stock's GF Value™ is €74.31, compared to a current price of €64.50 — trading 13.2% below its estimated fair value. The current Total Liabilities is €1,384 Mil. Haemonetics' overall GF Score™ is 83/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Haemonetics (STU:HAZ), the current Total Liabilities is €1,384 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Haemonetics (STU:HAZ) Overvalued in 2026?

Based on GuruFocus' analysis, Haemonetics stock appears to be undervalued. The current stock price of €64.50 is trading 13.2% below its estimated GF Value™ of €74.31.

Key valuation signals for STU:HAZ:

  • Total Liabilities: €1,384 Mil
  • GF Value™: €74.31 vs. price of €64.50 (13.2% below fair value)
  • GF Score™: 83/100 with 4 warning signs

No single metric tells the full story. See the STU:HAZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Haemonetics Business Description

Other Exchanges HAE:USA
Address 125 Summer Street, Boston, MA, USA, 02110
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.
83GF Score

Get the complete analysis for STU:HAZ

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€64.50
Price
€74.31
GF Value